It does not happen too often that a patent is declared invalid by the CAFC due to a translation mistake, but this is what happened in  IBSA Institut Biochemique, S.A. v. Teva Pharmaceuticals USA, Inc. Quite a bit has been written about this decision already (for example here and here and here), so I will concentrate on some translation-related aspects of this case.